未治疗早期关节炎患者类风湿关节炎风险位点的CD4+和B淋巴细胞表达数量性状:对因果基因鉴定的启示
研究对344例未接受免疫调节治疗的早期关节炎患者外周血纯化B细胞和/或CD4+ T细胞进行基因分型和全基因表达检测,分析与非HLA类风湿关节炎单核苷酸多态性处于连锁不平衡(r2≥0.8)的变异,寻找顺式或反式表达数量性状位点。结果发现FADS1、FADS2、BLK、FCRL3、ORMDL3、PPIL3和GSDMB在CD4+和B淋巴细胞中均存在顺式eQTL,METTL21B、JAZF1、IKZF3和PADI4的eQTL仅见于CD4+淋巴细胞,SYNGR1和CD83存在B淋巴细胞特异性eQTL,8p23 BLK-FAM167A位点邻近基因的eQTL活性在细胞类型间差异显著。未发现反式eQTL达到实验-wide显著性,线性模型未发现生物学协变量对顺式eQTL效应量的显著影响。
要点
- 在未治疗早期关节炎患者中,CD4+和B淋巴细胞共享FADS1、FADS2、BLK、FCRL3、ORMDL3、PPIL3和GSDMB的顺式eQTL。
- METTL21B、JAZF1、IKZF3和PADI4的eQTL仅见于CD4+淋巴细胞,PADI4为首次在该细胞亚群中识别。
- SYNGR1和CD83存在B淋巴细胞特异性eQTL,8p23 BLK-FAM167A位点FAM167A效应显示显著B淋巴细胞特异性。
核心结论
- 这些发现进一步细化了对类风湿关节炎发病机制中候选因果基因的理解,为优先开展针对特定细胞类型的下游功能研究提供了重要平台。
研究设计与样本
- 从344例未接受治疗性免疫调节的早期关节炎患者外周血中分离纯化B细胞和/或CD4+ T细胞,提取RNA和DNA。
- 采用Illumina BeadChip微阵列进行基因分型和全基因表达检测。
- 分析与非HLA类风湿关节炎单核苷酸多态性处于连锁不平衡(定义为r2≥0.8)的变异,根据关联探针是否位于这些连锁不平衡区块4 Mb范围内寻找顺式或反式eQTL证据。
主要发现
- 在类风湿关节炎风险位点,CD4+和B淋巴细胞共有的顺式eQTL效应基因为FADS1、FADS2、BLK、FCRL3、ORMDL3、PPIL3和GSDMB。
- 作用于METTL21B、JAZF1、IKZF3和PADI4的顺式eQTL仅见于CD4+淋巴细胞,其中PADI4为首次在该细胞亚群中识别。
- 还发现SYNGR1和CD83的B淋巴细胞特异性eQTL。
- 在8p23 BLK-FAM167A位点,邻近基因受eQTL影响且活性在细胞类型间差异显著,特别是FAM167A效应显示显著的B淋巴细胞特异性。
- 没有反式eQTL接近实验-wide显著性,线性模型未发现生物学协变量对顺式eQTL效应量有显著影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Rheumatoid arthritis (RA) is a genetically complex disease of immune dysregulation. This study sought to gain further insight into the genetic risk mechanisms of RA by conducting an expression quantitative trait locus (eQTL) analysis of confirmed genetic risk loci in CD4+ T cells and B cells from carefully phenotyped patients with early arthritis who were naive to therapeutic immunomodulation. METHODS: RNA and DNA were isolated from purified B and/or CD4+ T cells obtained from the peripheral blood of 344 patients with early arthritis. Genotyping and global gene expression measurements were carried out using Illumina BeadChip microarrays. Variants in linkage disequilibrium (LD) with non-HLA RA single-nucleotide polymorphisms (defined as r2 ≥ 0.8) were analyzed, seeking evidence of cis- or trans-eQTLs according to whether the associated probes were or were not within 4 Mb of these LD blocks. RESULTS: Genes subject to cis-eQTL effects that were common to both CD4+ and B lymphocytes at RA risk loci were FADS1, FADS2, BLK, FCRL3, ORMDL3, PPIL3, and GSDMB. In contrast, those acting on METTL21B, JAZF1, IKZF3, and PADI4 were unique to CD4+ lymphocytes, with the latter candidate risk gene being identified for the first time in this cell subset. B lymphocyte-specific eQTLs for SYNGR1 and CD83 were also found. At the 8p23 BLK-FAM167A locus, adjacent genes were subject to eQTLs whose activity differed markedly between cell types; in particular, the FAM167A effect displayed striking B lymphocyte specificity. No trans-eQTLs approached experiment-wide significance, and linear modeling did not identify a significant influence of biologic covariates on cis-eQTL effect sizes. CONCLUSION: These findings further refine the understanding of candidate causal genes in RA pathogenesis, thus providing an important platform from which downstream functional studies, directed toward particular cell types, may be prioritized.
引用
- Thalayasingam N, Nair N, Skelton AJ, et al. CD4+ and B Lymphocyte Expression Quantitative Traits at Rheumatoid Arthritis Risk Loci in Patients With Untreated Early Arthritis: Implications for Causal Gene Identification. Arthritis Rheumatol. 2018. PMID: 29193869. doi:10.1002/art.40393
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。